Spurious
Shanghai
About Spurious
Sipurui is a pharmaceutical company specializing in the development of small molecule anti-tumor drugs, with a particular emphasis on iterative innovation to enhance the efficacy and selectivity of cancer therapies.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Total funding: $62.8M
- Funding stage: Seed
- Last round: Seed (Jan 2026)
Industries & Categories
Health Care
Canonical: https://fsome.com/organization/spurious-152583 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.